azithromycin pediatric suspension
Selected indexed studies
- Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. (Antimicrob Agents Chemother, 1993) [PMID:8383944]
- Azithromycin oral suspension in prevention and management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial. (Support Care Cancer, 2022) [PMID:34259920]
- Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. (Pediatr Infect Dis J, 2000) [PMID:11144401]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and azithromycin in pediatric patients. (2000) pubmed
- Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. (1993) pubmed
- Azithromycin oral suspension in prevention and management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial. (2022) pubmed
- Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update. (2004) pubmed
- Access to medicines for children in China. (2022) pubmed
- Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. (1995) pubmed
- The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. (1996) pubmed
- History of macrolide use in pediatrics. (1997) pubmed
- Paediatric safety of azithromycin: worldwide experience. (1996) pubmed
- Impact of extemporaneous compounding on palatability, and in vitro bioaccessibility of azithromycin dry suspension assessed by electronic tongue and a dynamic gastrointestinal system (DHSI-IV). (2025) pubmed